MB
LinkedIn

Menaka Bhor

GRWE Director

Greater Houston · 1 connection

Sobi - Swedish Orphan Biovitrum AB (publ)

Not on Unlinked · Imported profile. Is this you? Claim it

About

With over 18 years of experience in health economics and outcomes research, I am now Director of HEOR & RWE (North America) at Sobi focusing on rare disease. My journey in HEOR has equipped me with a robust skill set in developing and executing integrated Value Evidence Plans in multiple therapeutic areas with a positive impact. Expert in: • Value Evidence & Outcomes Research • Health Economic Modeling • Real-World Evidence (RWE) generation • Regulatory strategy and FDA interactions • Cross-functional collaboration • Patient-Reported Outcomes (PRO) • Market Access and Pricing strategies Key Accomplishments: • Spearheaded the development of economic models for Bexsero, influencing critical NITAG decisions and pricing strategies. • Led a multicenter observational study in oncology, ensuring regulatory compliance and alignment with FDA guidance. • Developed comprehensive economic models for Barrett’s esophagus, enhancing clinical validation and stakeholder engagement. • Supported market access strategies for advanced treatments in sickle cell disease, collaborating with teams to deliver compelling evidence packages. Let's connect to discuss how we can collaborate on innovative healthc

Experience

VEO Director, VaccinesGSK
Jan 2023
HEOR Director, Oncology Cell and Gene TherapyGSK
May 2022 to Dec 2022
Director, HEORExact Sciences
Jul 2020 to May 2022
Associate DirectorNovartis
Dec 2015 to Jul 2020
Director, HEORCardinal Health
Feb 2014 to Nov 2015
Lead Outcome ResearcherMcKesson
Jun 2012 to Jan 2014
Outcomes ResearcherMcKesson
Nov 2011 to May 2012
Senior ManagerAbbott
Nov 2009 to Dec 2011
Manager (Health Economics and Outcomes Research)Abbott
Jul 2007 to Nov 2009

Education

Purdue University
Doctor of Philosophy (PhD) Pharmacy Administration and Pharmacy Policy and Regulatory Affairs
2000 to 2006